Compare Humana Inc (HUM) vs Norwegian Cruise Line Holdings Ltd (NCLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Norwegian Cruise Line Holdings Ltd — how do they compare? Humana Inc trades at $444.98 (market cap $47.61B), while Norwegian Cruise Line Holdings Ltd trades at $15.65 (market cap $6.91B). The key difference: Humana Inc is far larger — about 6.9× Norwegian Cruise Line Holdings Ltd's market cap, and Humana Inc pays a 0.89% dividend while Norwegian Cruise Line Holdings Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Norwegian Cruise Line Holdings Ltd for 68 Days on average.
| HUM | NCLH | |
|---|---|---|
Market Cap | $47.61B | $6.91B |
Volume | 1,827,332 | 25,654,210 |
Sector | Health | Consumer Cyclical |
52-Week High | $409.85 | $25.02 |
52-Week Low | $163.67 | $14.12 |
Typical Hold Time | 53 Days | 68 Days |
Enterprise Value | $54.97B | $21.73B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.
The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.
Norwegian Cruise Line Holdings (NCLH) trades at $15.05, down 2.97% today, with neutral technical signals and strong analyst support. The company shows improving fundamentals with revenue growth from $9.5B in 2024 to $9.83B in 2025, though net income declined to $423M. Recent Q2 2026 earnings beat expectations at $0.48 EPS versus $0.41 expected, while management expects Q3 results to exceed guidance. Valuation remains attractive with P/E of 9.12 and P/S of 0.72.
NCLH presents a compelling value opportunity with analyst consensus price target of $20.86 offering 38% upside potential. However, investors face risks from persistent yield pressure, high debt levels ($11.78B long-term), and Caribbean pricing competition. The stock's outlook depends on successful execution of earlier booking strategies and maintaining EBITDA growth amid industry headwinds through 2027.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Norwegian Cruise Line Holdings Ltd
Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.
Read more on NCLH →
